Title |
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial |
|---|---|
Involved |
Anne Katrin Berger (Verfasser)
Stephan Lücke (Sonstige) Ulrich Abel (Sonstige) Georg Martin Haag (Sonstige)
Carsten Grüllich (Sonstige)
Annika Stange (Sonstige) Mareike Dietrich (Sonstige) Leonidas Apostolidis (Sonstige) Angelika Freitag (Sonstige) Claudia Trierweiler (Sonstige) Carl von Gall (Sonstige) Jennifer Ose (Sonstige) Frederik L. Giesel (Sonstige) Tim Weber (Sonstige) Florian Lordick (Sonstige) Uwe Haberkorn (Sonstige) Dirk Jäger (Sonstige) SpringerLink (Online service) (Sonstige) |
Published in |
British journal of cancer : BJC 119, 2, 2.7.2018, date:7.2018, Seite 170-175 |
Published |
2018 |
Language |
|
Country |
|
Topic |
|
Subject |
Biomedicine.
Biomedicine, general. Cancer Research. Epidemiology.
Molecular Medicine.
Oncology. Drug Resistance. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2018091802151750210394 (URN) |
Record ID |
1167235134 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: